AI Assistant
Blog
Pricing
Log In
Sign Up
Development of pediatric orally disintegrating mini-tablets containing atomoxetine hydrochloride-β-cyclodextrin inclusion complex using experimental design
Details
Cite
Export
Add to List
This content is not available in your region!
Continue researching
here.